Research halted on rimonabantSanofi-Aventis has discontinued further development of rimonabant for all therapeutic indications. Diabetes patients in Alberta rural areas missing out on reductions in mortality Diabetes meds underused, taken irregularly in Quebec Cardiovascular protective therapies also underused among these diabetic patients Combo offers no heart attack relief for diabetics Canada lands 10th on international health indicators comparison Vaccine reduces risk of shingles in older adults Angeliq: continuous therapy for menopausal symptoms Bayer is introducing Angeliq (drospirenone 1 mg and estradiol-17 OMA looks to next four years Deal OK’d but only 34% voted Mastering images with impact An encounter with polar bears launches an award-winning photographic career Clincal in Brief - Nov 4 2008 First Previous 501 502 503 504 505 Next Last
